Outcomes for Patients With Cancer Admitted to the ICU Requiring Ventilatory Support

Azevedo, Luciano César Pontes; Caruso, Pedro; Silva, Ulysses V. A.; Torelly, André P.; Silva, Eliézer; Rezende, Ederlon; Netto, José Jorge Soares; Piras, Cláudio; Lobo, Suzana Margareth; Knibel, Marcos Freitas; Teles, José; Lima, R; Ferreira, Bruna Gil; Friedman, Gilberto; Réa-Neto, Álvaro; Dal‐Pizzol, Felipe; Bozza, Fernando A.; Salluh, Jorge I.; Soares, Márcio

doi:10.1378/chest.13-1870

Cited by 154 publications

(107 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…But, transthoracic needle aspiration is the most common diagnostic techniques for such locations with a pooled sensitivity of 90%. In a patient with a malignant pleural effusion, pleural fluid cytology is reported to have a mean sensitivity of about 72% (15,16). In accordance with this data our results showed that bronchoscopy was the most common diagnostic method in general, and in patients with SCC and SCLC which tend to locate centrally; and, transthoracic lung biopsy was the common method in AC which tends to locate periphery.…”

Section: Discussionsupporting

confidence: 85%

The importance of lung cancer in intensive care mortality, a retrospective mortality assessment

2015

J Chest Dis Crit Care

View full text Add to dashboard Cite

Time depended variability in the data of lung cancer by the time, makes it necessary to make informational updates and mortality analysis.In this study, we aimed to make a mortality assessment in cases died from lung cancer in intensive care. Data of patients died from lung cancer in intensive care between January 2013 and January 2015 were retrospectively reviewed. 810 patients have been hospitalized in the intensive care and 420 patients have been hospitalized in the respiratory intensive care. 118 had been diagnosed with primary lung cancer. 56 of the deaths in respiratory intensive care were identified as primary lung cancer and mortality rate of lung cancer cases in intensive care was 47.4% and its proportions in general mortality of intensive care and respiratory intensive care were 21.6% and 45.2% respectively. 11 cases were female and 45 cases were male. The most common cancer types are squamous cell carcinoma (SCC) in general, adenocancer (AC) in females and SCC in males. Smoking rates showed significant differences between genders (45.5% in females and 91.1% in males). Small cell lung cancer (SCLC) has the strongest relation with smoking. While the most common diagnostic procedure was bronchoscopy in general, in SCC and SCLC, transthoracic lung biopsy was the common method in AC. Mean survival times showed significant difference between cancer types and SCLC had the shortest survival time. Mean survival was significantly low in patients with distant organ metastasis. Respiratory failure was the most common indication for intensive care intake. Pneumonia and MODS-sepsis were the most common death causes in all cases. Consequently, lung cancer has a significant proportion in intensive care mortality and the mortality rate of lung cancer is significantly associated to cancer type and metastasis status.

show abstract

Section: Discussionsupporting

confidence: 85%

The importance of lung cancer in intensive care mortality, a retrospective mortality assessment

2015

J Chest Dis Crit Care

View full text Add to dashboard Cite

show abstract

“…Moreover, overall NIV failure rates exceeded 70 %, particularly in more severely ill patients. In previous studies in cancer patients, ARDS was associated with NIV failure [6][7][8]. Therefore, the present study provides additional evidence that NIV should not be standard first-line support for the oncological/hematological patient with ARDS.…”

supporting

confidence: 54%

Cancer patients with ARDS: survival gains and unanswered questions

Depuydt

Soares

2014

Intensive Care Med

View full text Add to dashboard Cite

“…The study by van Vliet and colleagues represents an important step in this direction. Similar milestone studies have been published from France and Belgium and from Brazil [9,10]. However, more studies are needed which provide more insight into the role of type and status of malignancy, the timing and reason for admission to the ICU and the nature and number of organ failure in predicting the outcome of ICU admission.…”

mentioning

confidence: 67%

Improved outcome of critically ill patients with hematological malignancies: what’s next?

Soubani

Decruyenaere

2014

Intensive Care Med

View full text Add to dashboard Cite

Outcomes for Patients With Cancer Admitted to the ICU Requiring Ventilatory Support

Cited by 154 publications

References 35 publications

The importance of lung cancer in intensive care mortality, a retrospective mortality assessment

The importance of lung cancer in intensive care mortality, a retrospective mortality assessment

Cancer patients with ARDS: survival gains and unanswered questions

Improved outcome of critically ill patients with hematological malignancies: what’s next?

Contact Info

Product

Resources

About